ARp7 inhibitors belong to a distinctive class of chemical compounds that have garnered significant attention due to their ability to modulate the activity of ARp7, an ATPase RNA helicase A and DExH-box helicase 9 enzyme. This class of inhibitors encompasses a diverse array of molecules, each possessing unique structural features and mechanisms of action that enable them to interfere with the functioning of ARp7. Structurally, ARp7 inhibitors exhibit a wide range of chemical scaffolds, including small molecules and natural compounds, which allow for their engagement with ARp7's active sites and interaction surfaces. At a mechanistic level, these inhibitors exert their effects through various routes. Some ARp7 inhibitors impede the helicase activity of the enzyme, thereby obstructing its role in unwinding RNA helices and modulating RNA structures. Others interfere with protein-protein interactions involving ARp7, disrupting its associations with other cellular components critical for its function. In addition, certain inhibitors might target ARp7 indirectly by affecting the overall cellular environment or specific signaling pathways that are intricately connected with ARp7's activity.
The pursuit of ARp7 inhibitors has led to the exploration of different molecular targets and cellular pathways, illuminating the complex network of interactions that ARp7 engages in. Researchers have delved into the three-dimensional structures of ARp7 and its binding partners, aiming to design inhibitors with enhanced specificity and affinity. Furthermore, these inhibitors have been subject to rigorous biochemical and biophysical characterization to decipher their modes of action and to understand how they interfere with ARp7's intricate functions within the cellular machinery. The realm of ARp7 inhibitors is a dynamic landscape, with ongoing investigations continually uncovering new insights into their mechanisms of action and potential applications. As the understanding of ARp7's role in cellular processes deepens, the development and optimization of inhibitors within this chemical class hold promise for expanding our understanding of fundamental biological mechanisms and potentially opening avenues for future research.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
P276-00 | 920113-03-7 | sc-477932 | 1 mg | $380.00 | ||
A cyclin-dependent kinase inhibitor with potential anticancer activity, partially achieved by targeting ARp7. | ||||||
Dinaciclib | 779353-01-4 | sc-364483 sc-364483A | 5 mg 25 mg | $247.00 $888.00 | 1 | |
A cyclin-dependent kinase inhibitor that might indirectly impact ARp7 through its effects on transcription and cell cycle regulation. | ||||||
Garcinol | 78824-30-3 | sc-200891 sc-200891A | 10 mg 50 mg | $124.00 $502.00 | 13 | |
A natural compound that exhibits anti-cancer properties, and its mechanism of action may involve the inhibition of ARp7. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
A compound that interferes with splicing by targeting the SF3b complex, indirectly influencing ARp7 activity. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
A natural compound that inhibits transcription by targeting RNA polymerase II, which could indirectly affect ARp7's role in RNA metabolism. | ||||||